Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Check out our latest pump and CGM insights from our trip to London earlier this month.
Recently, the diaTribe team attended the annual Diabetes Technology Society conference here in San Francisco. Several people from academia and the pharma industry...
We are eagerly waiting for the fall premiere of Taking Control of Your Own Diabetes (TCOYD)’s new groundbreaking online reality TV show, Extreme Diabetes Makeover (XDM...
A next gen weight management and fitness tool— type 1 patient Adam Brown shares his thoughts on BodyMedia’s FIT Weight Management System.
Insulet's OmniPod will now be available in Canada. GlaxoSmithKline is partnering with Insulet to make the OmniPod available in Canada for the first time. Under the new...
Academy Award winner Olympia Dukakis and her husband Louis Zorich are campaigning to increase diabetes awareness. While 18 million people are currently diagnosed with...
Kerri Morrone Sparling takes the next step: her path to CGM.
Although no one ever said insulin pump management was easy, we’re very happy that new tools are emerging that can make pumping easier and better. We have often wondered...
Three famous doctors on blood glucose monitoring, Byetta/Victoza, and insulin pumps.
In mid-April, the European Medicine Agency's Committee for Medicinal Products for Human Use (a committee called the "CHMP") recommended that Amylin/Lilly/Alkermes' once-...
One of the most interesting exhibits at this year's ADA Scientific Sessions was the booth showcasing the "JewelPUMP,” a new patch pump based on MEMS micro-pump...
Kerri Morrone Sparling discusses what an active patient she was while under the captivity of bed rest.
Kerri Morrone Sparling reviews the 2nd annual Roche Social Media Summit – and the real change put into action as a result of the first Summit.
In a major setback for MannKind Corporation ’s inhalable insulin therapy, Afrezza, the FDA is requiring the company to conduct two additional clinical trials of the...
Kelly shares her thoughts on recent reimbursement and regulatory news for diabetes devices.
A few years ago, Dr. Steven Nissen and Dr. Kathy Wolski of the Cleveland Clinic published an analysis of several clinical studies that stirred controversy regarding the...
Every year on November 14, we pay homage to everyone living with or caring for someone with diabetes on World Diabetes Day . First celebrated in 2007 following a UN...
Kelly laments the FDA's latest disappointing decision and extends a personal invitation to celebrate World Diabetes Day with the diaTribe team .
Novo Nordisk’s once daily GLP-1 agonist Victoza (above) provided slightly better improvements in blood glucose control than Amylin/Eli Lilly/ Alkermes’s once weekly GLP-...
Kerri Morrone Sparling advocates for unity in the diabetes community.

Pages